The purpose of this review is to discuss the status of COVID-19 among people with diabetes, those who have just been diagnosed with diabetes, diabetic ketoacidosis, and programmatic efforts like vaccinations at the present time. Diabetes has been identified as one of the most common comorbidities among COVID-19 patients in the majority of studies conducted in Saudi Arabia. There are currently only a few studies from Saudi Arabia on COVID-19-related newly diagnosed diabetes and diabetic ketoacidosis. Comprehensive guidelines and vaccinations in order of priority have been implemented by the Saudi ministry to reduce the impact of COVID-19 on diabetics. The utilization of tele health services significantly increased in Saudi Arabia's diabetes clinics during the COVID-19 pandemic. To manage the effects of COVID-19 on diabetics, targeted, evidence-based interventions are essential.
